Clinical trial

Impact of Smoking and Its Cessation on Systemic and Airway Immune Activation

NCT02836067

Study summary

ClinicalTrials.gov

Impact of Smoking and Its Cessation on Systemic and Airway Immune Activation

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

BEHAVIORAL · Unmapped registry intervention Counseling Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Smoking Cessation drugs Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Bronchoscopy Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Blood Draw Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Questionnaires Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-06-15

PhaseNA

Conditions

HIVunresolved

Smokingunresolved

Interventions

CounselingBEHAVIORAL

Smoking Cessation drugsOTHER

BronchoscopyPROCEDURE

Blood DrawPROCEDURE

QuestionnairesBEHAVIORAL

Sponsors & collaborators

Boston Medical Centerlead sponsor

National Institute on Drug Abuse (NIDA)collaborator

Mapped research locations

BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02836067 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.